TEVA
Teva Pharmaceutical·NYSE
--
--(--)
--
--(--)
TEVA fundamentals
Teva Pharmaceutical (TEVA) Revenue Breakdown: Q3 2025 Business & Regional Performance
Teva Pharmaceutical (TEVA) reported total revenue of 4.48B USD in Q3 2025, with its core business segment Goods contributing 87.21%. Regionally, United States remained the largest market, accounting for 56.10% of total revenue. Explore Teva Pharmaceutical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Teva Pharmaceutical (TEVA) reported total revenue of 4.48B USD in Q3 2025, with its core business segment Goods contributing 87.21%. Regionally, United States remained the largest market, accounting for 56.10% of total revenue. Explore Teva Pharmaceutical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Teva Pharmaceutical's management provide for the next earnings period?What is Teva Pharmaceutical's gross profit margin?What is Teva Pharmaceutical's latest dividend and current dividend yield?What were the key takeaways from Teva Pharmaceutical's earnings call?What does Teva Pharmaceutical do and what are its main business segments?What is the market's earnings forecast for Teva Pharmaceutical next quarter?What were the key takeaways from Teva Pharmaceutical’s earnings call?Did Teva Pharmaceutical beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
